| scholarly article | Q13442814 |
| review article | Q7318358 |
| P356 | DOI | 10.1111/PEDI.12392 |
| P698 | PubMed publication ID | 27411433 |
| P50 | author | Olli Helminen | Q57303419 |
| Riitta Veijola | Q40817090 | ||
| P2093 | author name string | Anne Hekkala | |
| Maarit Koskinen | |||
| P2860 | cites work | Type 1 diabetes | Q27000491 |
| Children followed in the TEDDY study are diagnosed with type 1 diabetes at an early stage of disease | Q30407805 | ||
| Acceleration of the loss of the first-phase insulin response during the progression to type 1 diabetes in diabetes prevention trial-type 1 participants | Q30557549 | ||
| Trends of earlier and later responses of C-peptide to oral glucose challenges with progression to type 1 diabetes in diabetes prevention trial-type 1 participants | Q33683763 | ||
| Early hyperglycemia detected by continuous glucose monitoring in children at risk for type 1 diabetes | Q33793829 | ||
| Age-related differences in the frequency of ketoacidosis at diagnosis of type 1 diabetes in children and adolescents | Q33932699 | ||
| Reduced morbidity at diagnosis and improved glycemic control in children previously enrolled in DiPiS follow-up | Q34308095 | ||
| Metabolic tests to determine risk for type 1 diabetes in clinical trials | Q35182110 | ||
| The 6 year incidence of diabetes-associated autoantibodies in genetically at-risk children: the TEDDY study | Q35371094 | ||
| Reduced prevalence of diabetic ketoacidosis at diagnosis of type 1 diabetes in young children participating in longitudinal follow-up | Q35408379 | ||
| The metabolic progression to type 1 diabetes as indicated by serial oral glucose tolerance testing in the Diabetes Prevention Trial-type 1. | Q35976782 | ||
| Reduced β-cell function in early preclinical type 1 diabetes | Q36461183 | ||
| Seroconversion to multiple islet autoantibodies and risk of progression to diabetes in children | Q36932173 | ||
| The use of intermediate endpoints in the design of type 1 diabetes prevention trials | Q37094744 | ||
| Diabetic subjects diagnosed through the Diabetes Prevention Trial-Type 1 (DPT-1) are often asymptomatic with normal A1C at diabetes onset | Q37163792 | ||
| Incident dysglycemia and progression to type 1 diabetes among participants in the Diabetes Prevention Trial-Type 1 | Q37319146 | ||
| Staging presymptomatic type 1 diabetes: a scientific statement of JDRF, the Endocrine Society, and the American Diabetes Association | Q37659402 | ||
| Hyperglycemic clamp and oral glucose tolerance test for 3-year prediction of clinical onset in persistently autoantibody-positive offspring and siblings of type 1 diabetic patients. | Q39096821 | ||
| Time trends in the incidence of type 1 diabetes in Finnish children: a cohort study | Q40088313 | ||
| Predictive value of intravenous glucose tolerance test insulin secretion less than or greater than the first percentile in islet cell antibody positive relatives of type 1 (insulin-dependent) diabetic patients | Q42477104 | ||
| First-phase insulin response in young healthy children at genetic and immunological risk for Type I diabetes. | Q44253807 | ||
| Insulin secretion and sensitivity in the prediction of type 1 diabetes in children with advanced β-cell autoimmunity | Q45256653 | ||
| Relationship between glycaemic variability and hyperglycaemic clamp-derived functional variables in (impending) type 1 diabetes. | Q49110588 | ||
| OGTT and random plasma glucose in the prediction of type 1 diabetes and time to diagnosis. | Q51302837 | ||
| Incidence of Type 1 Diabetes in Finland | Q56637647 | ||
| P921 | main subject | type-1 diabetes | Q124407 |
| glycobiology | Q899224 | ||
| P304 | page(s) | 25-30 | |
| P577 | publication date | 2016-07-01 | |
| P1433 | published in | Pediatric Diabetes | Q7159203 |
| P1476 | title | Dysregulation of glucose metabolism in preclinical type 1 diabetes | |
| P478 | volume | 17 Suppl 22 |
| Q45324653 | A Coxsackievirus B vaccine protects against virus-induced diabetes in an experimental mouse model of type 1 diabetes |
| Q50120159 | Class II HLA Genotype Association with First Phase Insulin Response Is Explained by Islet Autoantibodies |
| Q47725669 | Glucose-stimulated insulin release: Parallel perifusion studies of free and hydrogel encapsulated human pancreatic islets. |
| Q53979046 | The DIPP project: 20 years of discovery in type 1 diabetes. |
| Q90726290 | The Effect of Recovery Warm-up Time Following Cold Storage on the Dynamic Glucose-stimulated Insulin Secretion of Isolated Human Islets |
| Q92982823 | Type 1 Diabetes: Disease Stratification |
| Q55016896 | Understanding Pre-Type 1 Diabetes: The Key to Prevention. |
Search more.